David Steinberg _e.040 Lab Rats To Unicorns podcast

Artwork

Innehåll tillhandahållet av John Flavin. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av John Flavin eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

Lab Rats to Unicorns « »
David Steinberg _e.040

1y ago 50:08

Dela

MP3•Episod hem

Innehåll tillhandahållet av John Flavin. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av John Flavin eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

e.040: David Steinberg is a General Partner at Longwood Fund. He is currently Chairman of the Board of Longwood portfolio companies Photys Therapeutics and Be Biopharma, where he also served as founding Chief Executive Officer, and serves on the board of Longwood portfolio companies AAVantgarde Bio, Carbon Biosciences, Lassen Therapeutics, and Rectify Pharmaceuticals.Previously, he was co-founder and Chief Innovation Officer of biotech venture creation firm PureTech Health (NASDAQ: PRTC), focusing on launching and investing in innovative biotech companies. David was the co-founder and CEO of several biotech companies, including Longwood-founded companies Pyxis Oncology (NASDAQ:PYXS) , Photys Therapeutics, Be Biopharma, and Carbon Biosciences as well as co-founder and CEO of Vor Biopharma (NASDAQ: VOR), Vedanta Biosciences, and Calix, and co-founder of Restorbio (NASDAQ:TORC). He previously worked in biopharma strategy consulting at Boston Consulting Group and Vertex Partners, and R&D at P&G Pharmaceuticals. David received his MBA in strategy and finance from the University of Chicago Booth School of Business and holds a BA in biology from Cornell University.

… continue reading

63 episoder

Artwork

David Steinberg _e.040

Lab Rats to Unicorns

published 1y ago

Dela

MP3•Episod hem

Innehåll tillhandahållet av John Flavin. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av John Flavin eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.

e.040: David Steinberg is a General Partner at Longwood Fund. He is currently Chairman of the Board of Longwood portfolio companies Photys Therapeutics and Be Biopharma, where he also served as founding Chief Executive Officer, and serves on the board of Longwood portfolio companies AAVantgarde Bio, Carbon Biosciences, Lassen Therapeutics, and Rectify Pharmaceuticals.Previously, he was co-founder and Chief Innovation Officer of biotech venture creation firm PureTech Health (NASDAQ: PRTC), focusing on launching and investing in innovative biotech companies. David was the co-founder and CEO of several biotech companies, including Longwood-founded companies Pyxis Oncology (NASDAQ:PYXS) , Photys Therapeutics, Be Biopharma, and Carbon Biosciences as well as co-founder and CEO of Vor Biopharma (NASDAQ: VOR), Vedanta Biosciences, and Calix, and co-founder of Restorbio (NASDAQ:TORC). He previously worked in biopharma strategy consulting at Boston Consulting Group and Vertex Partners, and R&D at P&G Pharmaceuticals. David received his MBA in strategy and finance from the University of Chicago Booth School of Business and holds a BA in biology from Cornell University.

… continue reading

63 episoder

كل الحلقات

×

Välkommen till Player FM

Player FM scannar webben för högkvalitativa podcasts för dig att njuta av nu direkt. Den är den bästa podcast-appen och den fungerar med Android, Iphone och webben. Bli medlem för att synka prenumerationer mellan enheter.

Lyssna på 500+ ämnen